Tzielan Chang Lee, MD
Pediatric Rheumatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office at (650) 497-8000 to ask if they take your plan before you enroll.
Medicaid work
$5,512 in 2024
Medicaid paid $5,512 for 48 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 48 | $5,512 |
| 2024 | 48 | 1 | 18 | $5,512 |
| 2023 | 48 | 1 | 12 | $4,476 |
| 2022 | 197 | 5 | 59 | $9,058 |
| 2021 | 2,147 | 6 | 369 | $61,769 |
| 2020 | 60 | 1 | 17 | $5,139 |
| 2019 | 92 | 1 | 24 | $6,959 |
| 2018 | 121 | 1 | 23 | $8,595 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 48 | $4,476 |
2022
| Return visit (30+ min) | 34 | $2,808 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose | 59 | $2,240 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 53 | $2,100 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose | 29 | $1,040 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose | 22 | $870 |
2021
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 921 | $26,360 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 870 | $26,210 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose | 153 | $5,210 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose | 81 | $2,860 |
| Return visit (30+ min) | 13 | $1,129 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, for intramuscular use | 109 | $0 |
2020
| Return visit (30+ min) | 60 | $5,139 |
2019
| Return visit (30+ min) | 92 | $6,959 |
2018
| Return visit (30+ min) | 121 | $8,595 |
Professional record
- NPI
- 1366599607
- Licence
- CA A066221
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2080P0216X (2080P0216X); Pediatrics (208000000X); Federal specialty code 2083C0008X (2083C0008X)
- Mailing address
- 300 Pasteur Drive, A085, Stanford, CA, 94305
- NPI first listed
- 2007-01-05
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 730 Welch Rd, Palo Alto, CA, 94304